Transient Severe Liver Injury: A Unique Presentation of COVID-19 Disease in a Pediatric Patient
Vasiliki Sgouropoulou1, Euthymia Vargiami, Maria Kyriazi
1From the First Department of Pediatrics, Aristotle University Thessaloniki, Hippokration Hospital, Thessaloniki, Greece.
Insights
Coronavirus disease 2019 (COVID-19) can cause severe liver injury, even in children with mild symptoms. Prompt recognition of hepatic damage is crucial for effective management in pediatric patients.
Area of Science:
- Hepatology
- Virology
- Pediatric Medicine
Background:
- Hepatotoxicity is a recognized complication of coronavirus disease 2019 (COVID-19).
- The spectrum of liver injury in COVID-19 can range from mild transaminitis to severe hepatic dysfunction.
- Pediatric involvement in COVID-19 has been associated with various clinical manifestations, including liver injury.
Observation:
- A pediatric case of COVID-19 with a mild clinical phenotype is presented.
- This patient experienced transient but severe liver injury.
- The hepatic damage occurred despite the overall mild presentation of the disease.
Findings:
- Transient severe liver injury can occur in pediatric patients with COVID-19.
- Liver dysfunction may be present even in mild cases of coronavirus disease 2019.
- The severity of hepatic damage is not always correlated with the overall clinical severity of COVID-19 in children.
Implications:
- Healthcare providers should consider hepatic damage in the differential diagnosis of children with COVID-19, irrespective of symptom severity.
- Early identification and management of COVID-19-related liver injury are essential for improved patient outcomes.
- Further research is warranted to understand the mechanisms of COVID-19-induced hepatotoxicity in pediatric populations.
Abstract:
Liver dysfunction is highlighted by several studies as a relevant complication in the context of coronavirus disease 2019 (COVID-19). We present a pediatric patient with mild phenotype but transient severe liver injury. Hepatic damage should be considered even in mild cases of the disease to ensure prompt recognition and management.
Related Concept Videos
Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury I: Introduction
Acute Kidney Injury II: Pathophysiology
Esophageal Perforation-II: Clinical Manifestations and Management
Clinical Manifestations:
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...


